SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SBFM

Sunshine Biopharma Inc. (NASDAQ:SBFM)

US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
$2.23-$0.12 (-5.11%)
 
Market cap
$4.74M
Insider Score
Analyst consensus
Listed since
Feb 15, 2022
Market Cap$4.74M-99.2%
Revenue (ttm)n/a-5.2%
Net Incomen/a-3.0%
EPSn/a+90.8%
Shares Out2.12M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume22,935
Open$2.34
Previous Close$2.35
Day's Range$2.23 - $2.35
52-Week Range$2.23 - $464.00
Beta1.35
AnalystsBuy
Price Targetn/a
Earnings Daten/a
-5.11% (1D)
No price history available.

About SBFM

Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, and liver cancers. Notably, Adva-27a also demonstrates efficacy against multidrug-resistant cancer cells, encompassing pancreatic, breast, small-cell lung, and uterine sarcoma cells. The company is also progressing SBFM-PL4, a compound under development as an anti-coronavirus treatment. In addition to its drug development, Sunshine Biopharma markets a range of nutritional products, such as the Essential 9 tablet and the Essential Calcium-Vitamin D supplement, alongside other scientifically formulated dietary aids. A collaboration with the University of Georgia supports the ongoing advancement of SBFM-PL4 as an anti-coronavirus agent. The firm's headquarters are situated in Pointe-Claire, Canada.

Address
333 Las Olas Way, Fort Lauderdale, FL, 33301, US
Market Cap
5 million
Employees
50
Industrial Classification
Drug Manufacturers - Specialty & Generic
1 Day
-5.11%
5 Days
-17.41%
1 Month
-33.23%
6 Months
-97.68%
1 Year
-99.20%

$SBFM stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in SBFM holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SBFM's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SBFM Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New SBFM patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SBFM from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from SBFM’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
100% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.